Company / Revenue
TransMedics Group, Inc. Revenue History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$605.5M
FY2025
5-year range
$30.3M / $605.5M
FY2021-FY2025
Trend
+37.1%
vs FY2024
Sector context
#113 of 150
Health Care
What the data says
TransMedics Group, Inc.'s revenue of $605M is lower than 75% of companies in the Health Care sector (FY2025). Revenue has increased for 7 consecutive years, from $13M in FY2018 to $605M in FY2025.
Based on SEC 10-K filings.
$605M in FY2025 with a 5-year CAGR of +88.2%.
Improved from $242M to $605M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +86.4%
- 5-Year CAGR
- +88.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 150This company $605.5M Sector average $19.5B
▼
-96.9% below sector average
Key checks
Key Insights
- TransMedics Group, Inc.'s revenue has grown for 7 consecutive years.
- 5-year CAGR of +88.2%, indicating consistent growth.
- In FY2025, revenue increased 37.1% year-over-year.
- Ranks #113 out of 150 companies in the Health Care sector.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $605.5M | +37.1% |
| FY2024 | $441.5M | +82.7% |
| FY2023 | $241.6M | +158.5% |
| FY2022 | $93.5M | +208.8% |
| FY2021 | $30.3M | +18.0% |
| FY2020 | $25.6M | +8.6% |
| FY2019 | $23.6M | +81.3% |
| FY2018 | $13.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026